Literature DB >> 6635429

Selective primary health care: strategies for control of disease in the developing world. IX. Poliomyelitis.

F C Robbins, E O Nightingale.   

Abstract

Poliomyelitis is an acute viral disease primarily afflicting children. It can be very mild, permanently crippling, or fatal. In the developed nations, poliomyelitis is controlled by the use of trivalent vaccines: killed virus administered by injection and/or attenuated virus administered orally. The latter is cheaper. A combination of the two may be required in some tropical countries. In many developing nations poliomyelitis remains endemic and prevalent, especially in children; 37,747 cases were reported to the World Health Organization in 1979, but greater than 200,000 cases probably occurred. Socioeconomic improvement and public health measures (i.e., immunizations) remain the major strategies for control. While global eradication may be a more distant goal, poliomyelitis could be controlled better. Effective programs for control include safe, efficacious, and inexpensive vaccines; methods for successful management of vaccine delivery systems; commitment and training of health personnel; public education; commitment of funds; and research to improve vaccines and their delivery. The major obstacle to control of poliomyelitis is failure to immunize an adequate number of susceptible children. Development of strategies for immunization is crucial to elimination of poliomyelitis as a major world health problem.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6635429     DOI: 10.1093/clinids/5.5.957

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  2 in total

1.  Paralytic poliomyelitis in vaccinated children.

Authors:  R K Pamecha
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

2.  Strategies to control poliomyelitis in India.

Authors:  M Singh
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.